Isopropyl Alcohol

Isopropyl Alcohol

SCHEMBL547846

CC(C)O.CC(C)O.CC(C)O.Cl[Ti]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
LMNA P02545 1/20 0.67
TSHR P16473 3/20 0.43
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropyl Alcohol SCHEMBL22638753 0.82
Isopropyl Alcohol SCHEMBL18419254 0.82
Isopropyl Alcohol SCHEMBL7760752 0.82
Isopropyl Alcohol SCHEMBL5185751 0.82
Isopropyl Alcohol SCHEMBL768800 0.82 ALDH1A1 (0.75) ALDH1A1LMNATSHRTDP1TP53
Isopropyl Alcohol SCHEMBL29814955 0.82
Isopropyl Alcohol SCHEMBL29500440 0.82
Isopropyl Alcohol SCHEMBL385 0.82
Isopropyl Alcohol SCHEMBL10729977 0.82 ALDH1A1 (1.00) ALDH1A1LMNATSHRTDP1TP53
Isopropyl Alcohol SCHEMBL16914724 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382347-B2 Ziegler-Natta catalysts doped with non-group IV metal chlorides FINA TECHNOLOGY INC (US) 2016-07-05 US claimed
US-8501653-B2 Heat-treated Ziegler-Natta catalysts for ethylene polymerization FINA TECHNOLOGY, INC. (US) 2013-08-06 US claimed
EP-2242577-B1 ZIEGLER-NATTA CATALYST FOR PARTICLE SIZE CONTROL FINA TECHNOLOGY (US) 2013-06-12 EP claimed
WO-2012112265-A1 ZIEGLER-NATTA CATALYSTS DOPED WITH NON-GROUP IV METAL CHLORIDE FINA TECHNOLOGY, INC. (US) 2012-08-23 WO claimed
WO-2012112264-A1 HEAT-TREATED ZIEGLER-NATTA CATALYSTS FOR ETHYLENE POLYMERIZATION FINA TECHNOLOGY, INC. (US) 2012-08-23 WO claimed
US-20120208969-A1 ZIEGLER-NATTA CATALYSTS DOPED WITH NON-GROUP IV METAL CHLORIDES FINA TECHNOLOGY, INC. (US) 2012-08-16 US claimed
US-20120208970-A1 HEAT-TREATED ZIEGLER-NATTA CATALYSTS FOR ETHYLENE POLYMERIZATION FINA TECHNOLOGY, INC. (US) 2012-08-16 US claimed
JP-2011508015-A 2011-03-10 JP claimed
EP-2242577-A1 ZIEGLER-NATTA CATALYST FOR PARTICLE SIZE CONTROL Fina Technology, Inc. (US) 2010-10-27 EP claimed
US-7655590-B2 Ziegler-Natta catalyst for particle size control FINA TECHNOLOGY, INC. (US) 2010-02-02 US claimed
WO-2009085677-A1 ZIEGLER-NATTA CATALYST FOR PARTICLE SIZE CONTROL FINA TECHNOLOGY, INC. (US) 2009-07-09 WO claimed
US-20090163680-A1 Ziegler-Natta catalyst for particle size control FINA TECHNOLOGY, INC. (US) 2009-06-25 US claimed
US-5095080-A Olefin polymerization catalyst and method for production and use PHILLIPS PETROLEUM COMPANY (US) 1992-03-10 US claimed
US-5068212-A Magnesium dihalide reacted with halogenated titanium alkoxide and contacting with titanium tetrachloride PHILLIPS PTROLEUM COMPANY (US) 1991-11-26 US claimed
US-20260062381-A1 METHODS FOR SYNTHESIS OF THE TRICYCLIC PROSTAGLANDIN D2 METABOLITE METHYL ESTER PURDUE RESEARCH FOUNDATION 2026-03-05 US disclosed
US-12466791-B2 Methods for synthesis of the tricyclic prostaglandin D2 metabolite methyl ester PURDUE RESEARCH FOUNDATION (US) 2025-11-11 US disclosed
EP-3154937-B1 CHLORINE-RESISTANT POLYETHYLENE COMPOUND AND ARTICLES MADE THEREFROM FINA TECHNOLOGY (US) 2024-05-22 EP disclosed
WO-1996018655-A1 HYDROGENATION OF UNSATURATED POLYMERS USING MONOCYCLOPENTADIENYL GROUP IV METAL CATALYSTS THE DOW CHEMICAL COMPANY (US) 1996-06-20 WO disclosed
US-5095080-A Olefin polymerization catalyst and method for production and use PHILLIPS PETROLEUM COMPANY (US) 1992-03-10 US disclosed
US-5068212-A Magnesium dihalide reacted with halogenated titanium alkoxide and contacting with titanium tetrachloride PHILLIPS PTROLEUM COMPANY (US) 1991-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12466791-B2 Methods for synthesis of the tricyclic prostaglandin D2 metabolite methyl ester PTGES2, PTGDR2, PTGES ALDH1A1 1309/4885LMNA 3179/4885TSHR 2412/4885
US-20260062381-A1 METHODS FOR SYNTHESIS OF THE TRICYCLIC PROSTAGLANDIN D2 METABOLITE METHYL ESTER PTGDR2, PTGDR, PTGES2 ALDH1A1 1398/4885LMNA 1916/4885TSHR 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.